Skip to content
Thursday, June 04, 2026
  • Business
  • Education
  • Entertainment
  • Health
  • Lifestyle
  • National
  • Press Release
  • Technology
Just News Now

Just News Now

  • Business
  • Education
  • Entertainment
  • Health
  • Lifestyle
  • National
  • Press Release
  • Technology
You are Here
  • Home
  • ISSARPharma

Tag: ISSARPharma

English Health Press Release

ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs

April 29, 2021

ISSAR Pharma, the only company in India which focuses on the research and development of New Chemical Entities (NCE), is licensing out its NCEs based

ISSARPharma, PeptidebasedNCEs, PNN

Recent Posts

  • VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share
  • eYantra Ventures Limited Reports FY26 Annual Results
  • VMS TMT Limited Announces Q4 FY26 and FY26 Results
  • PPMS Group Joins with Prashant Janadri for Activatr – Distribution Platform for Consumer Brands
  • UMC Hospitals, Navi Mumbai Successfully Performs Its First Robotic Surgery
  • Srigee DLM Ltd Announces H2 FY26 and FY26 Results
  • Human Experience Management for Solving Challenges in Employee Lifecycle
  • Remittix Smashes Through $30M, The Clock Is Now Ticking On An RTX Launch Date Reveal
  • India’s Blood Sugar Problem Is No Longer Only About Diabetes
  • Sathlokhar Synergys E&C Global Limited Registers Stellar FY26 Performance as Total Income Rises 121% YoY to Rs 824 Cr and PAT Surges 141% YoY to Rs 82 Cr

Mail us : [email protected]

All Rights Reserved 2023.
Proudly powered by WordPress | Theme: Recent News by Candid Themes.